To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Expanded Reagent and Dye Portfolio for Cellular Analysis
Read time: Less than a minute
BD Biosciences have announced the launch of the BD™ Kaleidoscope reagent and dye expansion program – marked by the initial release of nearly 200 new fluorochrome-conjugated antibodies for flow cytometry to help meet today’s life science research needs.
“Multicolor flow cytometry empowers researchers who are conducting complex experiments to analyze multiple parameters simultaneously, enhancing discovery and problem solving by providing them with a wealth of information in a single experiment,” said Jay Glasscock, President, Cell Analysis, BD Biosciences. “These 200 new products from the BD Kaleidoscope program represent simply the beginning of our significant portfolio expansion designed to support the growing base of applications that can benefit from this powerful technology.”
The BD Kaleidoscope portfolio offers these new fluorochrome-conjugated antibodies in a full range of colors, making it easier to construct multicolor cocktails to obtain fluorescently separated cell populations more efficiently. In addition, researchers can choose from a wide range of sizes, such as the new 50 test/50 mg size to reduce the cost of initial panel design and testing. The new BD reagents, like others in the BD Biosciences portfolio, are optimized for use with BD flow cytometry systems.
“Multicolor flow cytometry empowers researchers who are conducting complex experiments to analyze multiple parameters simultaneously, enhancing discovery and problem solving by providing them with a wealth of information in a single experiment,” said Jay Glasscock, President, Cell Analysis, BD Biosciences. “These 200 new products from the BD Kaleidoscope program represent simply the beginning of our significant portfolio expansion designed to support the growing base of applications that can benefit from this powerful technology.”
The BD Kaleidoscope portfolio offers these new fluorochrome-conjugated antibodies in a full range of colors, making it easier to construct multicolor cocktails to obtain fluorescently separated cell populations more efficiently. In addition, researchers can choose from a wide range of sizes, such as the new 50 test/50 mg size to reduce the cost of initial panel design and testing. The new BD reagents, like others in the BD Biosciences portfolio, are optimized for use with BD flow cytometry systems.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
